Pediatric rheumatology

Screening utility and acceptability of the Kiswahili-pGALS (paediatric Gait, Arms, Legs, Spine) at a tertiary referral hospital in Kenya-A diagnostic accuracy study

Pediatr Rheumatol Online JPublished Diagnostic accuracy study

Authors' conclusion

The Kiswahili-pGALS's was found to be a useful screening tool to aid early identification of MSK conditions in Kiswahili-speaking settings.

Study context

Population
Kiswahili-speaking children aged 5–16 years with symptoms suggestive of an musculoskeletal (MSK) condition presenting at the Aga Khan University Hospital's (AKUH) ED, Kenyamedian age 9 years (IQR 7–11)
Participants
100 children
Comparison
Kiswahili-pGALS by resident doctors vs paediatric rheumatologist examination (gold standard)
Outcome
Diagnostic accuracy of the Kiswahili-pGALS vs the reference standard
Methodological detailssystematic random sampling, reference standard blinded to index test, single-centre
  • Systematic random sampling
  • Reference standard blinded to index test
  • Single-centre

Performance

As reported in the abstract

Diagnostic accuracy for MSK conditions
Test or modelSensitivitySpecificityDiagnostic accuracyAUC
Kiswahili-pGALS76.8% (95%CI 63.6-87.0%)40.0% (95%CI 23.9-57.9%)62.7% (95%CI 52.1-72.1%)0.58 (95%CI 0.48-0.68)

Kiswahili-pGALS

Sensitivity76.8% (95%CI 63.6-87.0%)
Specificity40.0% (95%CI 23.9-57.9%)
Diagnostic accuracy62.7% (95%CI 52.1-72.1%)
AUC0.58 (95%CI 0.48-0.68)

Further findings

Acceptability: guardians reporting none or only some discomfort — Kiswahili-pGALS
Ninety percent
Time to perform Kiswahili-pGALS
5.0 · median · IQR 3.5–6.0 · min

Original publication

Screening utility and acceptability of the Kiswahili-pGALS (paediatric Gait, Arms, Legs, Spine) at a tertiary referral hospital in Kenya-A diagnostic accuracy study. Pediatr Rheumatol Online J. Published 18 September 2023. doi:10.1186/s12969-023-00882-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.